샘플 요청 목록

 카트 문의
시장보고서
상품코드
1398762

기질 혈관 분획 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2031년) - 제품별, 용도별, 최종사용자별, 지역별

Stromal Vascular Fraction Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 183 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 기질 혈관 분획(SVF) 시장 규모는 2024년 약 9,600만 달러에 달할 것으로 예상되며, 2031년 말에는 약 1억 3,100만 달러에 달할 것으로 전망됩니다. 시장 발전의 원동력은 자동화된 새로운 POC(Point of Care) 장비의 개발, 비용 효율성, SVF 치료의 채택 확대입니다.

SVF를 포함한 줄기세포 치료는 헬스케어 분야에서 큰 잠재력을 가지고 있습니다. 그러나 SVF 치료의 실용화는 많은 의료 시설에서 지식, 인프라 및 장비 측면에서 어려움을 겪고 있습니다. 이러한 장애물을 극복하기 위해 기업과 연구기관들은 SVF 분리 과정을 간소화하는 자동 POC 장비를 개발하고 있습니다. 이러한 장비는 운송의 필요성을 없애고, 처리 비용을 절감하며, 조직에 최소한의 조작으로 큰 이점을 제공합니다. 비용 절감, 사용 편의성 및 환자 결과 개선이 시장 성장의 주요 동인입니다.

SVF 시장 성장의 과제는 규제 준수 문제, 고도의 인프라 구축 필요성 등이 있습니다. 과거에는 일부 의료기기 제조업체들이 규제의 테두리를 넘어 제품을 밀어붙여 환자들의 인식과 지방유래 줄기세포 치료의 채택에 영향을 미치기도 했습니다. 환자의 안전을 보장하기 위해서는 규제 준수가 필수적입니다.

클린룸 시설, 특수 장비, 기술력, cGMP 준수와 같은 인프라 요구 사항으로 인해 SVF의 도입은 도시 대형 병원에 국한되어 있습니다. 이러한 시술에 대한 보험급여를 받는 것은 여전히 어려운 일이며, 이는 시장 침투율을 떨어뜨리고 있습니다.

이 보고서는 세계 기질 혈관 분획 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • Porter's Five Forces 분석
  • COVID-19의 영향 분석
  • 우크라이나와 러시아의 분쟁의 영향
  • 경제 개요
  • PESTLE 분석

제3장 세계의 기질 혈관 분획 시장 전망, 2018-2031년

  • 세계의 기질 혈관 분획 시장 전망, 제품별, 금액(100만 달러), 2018-2031년
  • 세계의 기질 혈관 분획 시장 전망, 용도별, 금액(100만 달러), 2018-2031년
  • 세계의 기질 혈관 분획 시장 전망, 최종사용자별, 금액(100만 달러), 2018-2031년
  • 세계의 기질 혈관 분획 시장 전망, 지역별, 금액(100만 달러), 2018-2031년

제4장 북미의 기질 혈관 분획 시장 전망, 2018-2031년

제5장 유럽의 기질 혈관 분획 시장 전망, 2018-2031년

제6장 아시아태평양의 기질 혈관 분획 시장 전망, 2018-2031년

제7장 라틴아메리카의 기질 혈관 분획 시장 전망, 2018-2031년

제8장 중동 및 아프리카의 기질 혈관 분획 시장 전망, 2018-2031년

제9장 경쟁 상황

  • 부문별과 용도별 히트맵
  • 제조업체와 용도별 히트맵
  • 기업의 시장 점유율 분석, 2023년
  • 경쟁력 대시보드
  • 기업 개요
    • Cytori Therapeutics Inc.
    • IntelliCell BioSciences Inc.
    • Cellular Biomedicines Group, Inc.
    • GE Healthcare(Biosafe Group SA)
    • Lifecell Corporation(Allergen PLC)
    • Tissue Genesis Inc.
    • InGeneron, Inc.
    • Human med AG
    • MEDICAN CO., LTD
    • Hairline International
    • Genesis Biosystems, Inc.
    • iXCells Biotechnologies USA, LLC
    • Kyocera Corporation
    • Medikan International Inc

제10장 부록

ksm 24.01.05

The global Stromal Vascular Fraction (SVF) market, with revenues of approximately US$ 96 million in 2024, is on track to achieve a valuation of around US$ 131 million by the end of 2031. The market's growth is being driven by the development of new automated Point-of-Care (POC) devices, cost-effectiveness, and the rising adoption of SVF therapies.

Driving Growth: Development of Automated POC Devices

Stem cell therapies, including SVF procedures, hold great promise in healthcare. However, the practical implementation of SVF therapies faces challenges in terms of knowledge, infrastructure, and supplies in many healthcare facilities. To overcome these obstacles, companies and research laboratories are developing automated POC devices to streamline SVF isolation processes. These devices eliminate the need for transport, reduce processing costs, and offer significant advantages in terms of minimal manipulation of tissue. Cost savings, ease of use, and improved patient outcomes are key drivers of market growth.

Challenges: Regulatory Compliance and Infrastructure

Challenges to SVF market growth include regulatory compliance issues and the need for advanced infrastructure. In the past, some medical device companies pushed products beyond regulatory boundaries, impacting patient perceptions and adoption of adipose-derived stem cell therapies. Compliance with regulations is critical to ensure patient safety.

Infrastructure requirements, such as clean room facilities, specialized equipment, technical capabilities, and adherence to cGMP practices, limit SVF implementation to major hospitals in urban areas. Obtaining reimbursement for these procedures remains challenging, reducing market penetration.

Country-wise Insights

United States: Extensive Clinical Trials Fuel Demand

The U.S. market is booming due to a massive pipeline of SVF-derived cell therapies and extensive clinical trials assessing their efficacy for various purposes. The increasing number of clinical trials drives demand for SVF products, including proprietary SVF isolation devices and consumables.

India: Rise in Research and Development Activities

India is emerging as a lucrative market due to increased research and development activities focused on innovative SVF technologies. The expansion of private hospitals in rural areas contributes to market growth, making the Asian region attractive.

Germany: Musculoskeletal Disorders Drive Demand

Germany's growing aging population and rising awareness of stem cell therapy, particularly in musculoskeletal disorders like osteoarthritis, position the country as a prominent market for SVF treatments. Legal constraints on stem-cell research and therapy are expected to relax, further boosting market growth.

Competitive Landscape

Key market players emphasize product launches, strategic alliances, mergers, acquisitions, and facility expansions to enhance their market presence.

Key Companies in the Stromal Vascular Fraction (SVF) Market:

  • Cytori Therapeutics Inc.
  • IntelliCell BioSciences Inc.
  • Cellular Biomedicines Group, Inc.
  • GE Healthcare (Biosafe Group SA)
  • Lifecell Corporation (Allergen PLC)
  • Tissue Genesis Inc.
  • InGeneron, Inc.
  • Human med AG
  • MEDICAN CO., LTD
  • Hairline International
  • Genesis Biosystems, Inc.
  • iXCells Biotechnologies USA, LLC
  • Kyocera Corporation
  • Medikan International Inc.

Key Segments Covered in Manufacturing of Industry Research

Product:

  • SVF Aspiration Products
  • SVF Transfer Products
  • SVF Isolation Products
  • Enzymatic Isolation Products
  • Non-enzymatic Isolation Products
  • Automated POC Devices

Application:

  • Cosmetic Applications
  • Orthopedic Applications
  • Soft Tissue Applications
  • Others

End User:

  • Hospitals
  • Specialty Clinics
  • Stem Cell Banks/Laboratories
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Stromal Vascular Fraction Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 3.1. Global Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. SVF Aspiration Products
      • 3.1.1.2. SVF Transfer Products
      • 3.1.1.3. SVF Isolation Products
        • 3.1.1.3.1. Enzymatic Isolation Products
        • 3.1.1.3.2. Non-enzymatic Isolation Products
        • 3.1.1.3.3. Automated POC Devices
  • 3.2. Global Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Cosmetic Applications
      • 3.2.1.2. Orthopedic Applications
      • 3.2.1.3. Soft Tissue Applications
      • 3.2.1.4. Others
  • 3.3. Global Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Specialty Clinics
      • 3.3.1.3. Stem Cell Banks/Laboratories
      • 3.3.1.4. Others
  • 3.4. Global Stromal Vascular Fraction Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 4.1. North America Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. SVF Aspiration Products
      • 4.1.1.2. SVF Transfer Products
      • 4.1.1.3. SVF Isolation Products
        • 4.1.1.3.1. Enzymatic Isolation Products
        • 4.1.1.3.2. Non-enzymatic Isolation Products
        • 4.1.1.3.3. Automated POC Devices
  • 4.2. North America Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Cosmetic Applications
      • 4.2.1.2. Orthopedic Applications
      • 4.2.1.3. Soft Tissue Applications
      • 4.2.1.4. Others
  • 4.3. North America Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialty Clinics
      • 4.3.1.3. Stem Cell Banks/Laboratories
      • 4.3.1.4. Others
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.4.1.2. U.S. Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.3. U.S. Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.4.1.4. Canada Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.4.1.5. Canada Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.6. Canada Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 5.1. Europe Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. SVF Aspiration Products
      • 5.1.1.2. SVF Transfer Products
      • 5.1.1.3. SVF Isolation Products
        • 5.1.1.3.1. Enzymatic Isolation Products
        • 5.1.1.3.2. Non-enzymatic Isolation Products
        • 5.1.1.3.3. Automated POC Devices
  • 5.2. Europe Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Cosmetic Applications
      • 5.2.1.2. Orthopedic Applications
      • 5.2.1.3. Soft Tissue Applications
      • 5.2.1.4. Others
  • 5.3. Europe Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialty Clinics
      • 5.3.1.3. Stem Cell Banks/Laboratories
      • 5.3.1.4. Others
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.2. Germany Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.3. Germany Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.4. U.K. Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.5. U.K. Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.6. U.K. Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.7. France Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.8. France Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.9. France Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.10. Italy Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.11. Italy Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.12. Italy Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.13. Turkey Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.14. Turkey Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.15. Turkey Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.16. Russia Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.17. Russia Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.18. Russia Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. SVF Aspiration Products
      • 6.1.1.2. SVF Transfer Products
      • 6.1.1.3. SVF Isolation Products
        • 6.1.1.3.1. Enzymatic Isolation Products
        • 6.1.1.3.2. Non-enzymatic Isolation Products
        • 6.1.1.3.3. Automated POC Devices
  • 6.2. Asia Pacific Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Cosmetic Applications
      • 6.2.1.2. Orthopedic Applications
      • 6.2.1.3. Soft Tissue Applications
      • 6.2.1.4. Others
  • 6.3. Asia Pacific Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialty Clinics
      • 6.3.1.3. Stem Cell Banks/Laboratories
      • 6.3.1.4. Others
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.2. China Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.3. China Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.4. Japan Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.5. Japan Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.6. Japan Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.7. South Korea Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.8. South Korea Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.9. South Korea Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.10. India Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.11. India Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.12. India Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 7.1. Latin America Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. SVF Aspiration Products
      • 7.1.1.2. SVF Transfer Products
      • 7.1.1.3. SVF Isolation Products
        • 7.1.1.3.1. Enzymatic Isolation Products
        • 7.1.1.3.2. Non-enzymatic Isolation Products
        • 7.1.1.3.3. Automated POC Devices
  • 7.2. Latin America Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Cosmetic Applications
      • 7.2.1.2. Orthopedic Applications
      • 7.2.1.3. Soft Tissue Applications
      • 7.2.1.4. Others
  • 7.3. Latin America Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialty Clinics
      • 7.3.1.3. Stem Cell Banks/Laboratories
      • 7.3.1.4. Others
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.2. Brazil Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.3. Brazil Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.4. Mexico Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.5. Mexico Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.6. Mexico Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.7. Argentina Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.8. Argentina Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.9. Argentina Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Stromal Vascular Fraction Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. SVF Aspiration Products
      • 8.1.1.2. SVF Transfer Products
      • 8.1.1.3. SVF Isolation Products
        • 8.1.1.3.1. Enzymatic Isolation Products
        • 8.1.1.3.2. Non-enzymatic Isolation Products
        • 8.1.1.3.3. Automated POC Devices
  • 8.2. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Cosmetic Applications
      • 8.2.1.2. Orthopedic Applications
      • 8.2.1.3. Soft Tissue Applications
      • 8.2.1.4. Others
  • 8.3. Middle East & Africa Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialty Clinics
      • 8.3.1.3. Stem Cell Banks/Laboratories
      • 8.3.1.4. Others
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.2. GCC Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.3. GCC Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.4. South Africa Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.5. South Africa Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.6. South Africa Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.7. Egypt Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.8. Egypt Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.9. Egypt Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.10. Nigeria Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.11. Nigeria Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.12. Nigeria Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Segment 3 vs by Application Heat map
  • 9.2. Manufacturer vs by Application Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Cytori Therapeutics Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. IntelliCell BioSciences Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Cellular Biomedicines Group, Inc.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. GE Healthcare (Biosafe Group SA)
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Lifecell Corporation (Allergen PLC)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Tissue Genesis Inc.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. InGeneron, Inc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Human med AG
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. MEDICAN CO., LTD
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Hairline International
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Genesis Biosystems, Inc.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. iXCells Biotechnologies USA, LLC
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Kyocera Corporation
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Medikan International Inc
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제